按 Enter 到主內容區

CCMP98-RD-015 中草藥產業發展關鍵因子分析

  • 資料來源:中醫藥司
  • 建檔日期:102-08-12
  • 更新時間:106-06-15

中草藥產業發展關鍵因子分析

羅淑慧
財團法人生物技術開發中心
本計畫之目的,係在探討中草藥產業發展主要先進國家,在中草藥管理政策及法規制度對該國產業結構、企業策略、及競爭優勢之影響,以探究中草藥產業發展的關鍵管理政策及法規制度。本研究將分析中草藥產業先進國家(美、德、日、中)之相關管理政策及法規制度,探討其同、異點。並利用問卷調查及專家座談會,探討影響各國中草藥產業發展之關鍵管理政策及法規制度,及其對產業之「市場結構」、「企業策略」、「競爭優勢」之影響。並與我國現行法規及實施現況進行比較,就我國中草藥產業發展之「困境」,及全球產業發展趨勢,提供我國發展中草藥產業之建言、及修正不合時宜的管理政策與法規制度之參考。此外,亦將計畫執行所蒐集之資訊,彙編及出版中草藥產業年鑑,主要內容包括:全球產業現況及發展趨勢、主要先進國家及我國中草藥產業介紹、新技術趨勢、及我國中草藥廠商名錄,以供國內產官學研各界參考。
關鍵字:台灣;中草藥;管理政策;法規

Critical factor analysis of Chinese medicine industry

Shu-Hui Luo
Development Center for Biotechnology
The aim of this study is to exam the impacts of management and regulatory policy on industrial structure, business strategy, and the competitive advantages for herbal medicine in the major herbal medicine industry advanced countries. This will lead to the discussions of key factors in regulatory policy and regulations system. This research will analyze the similar and different approaches of related regulatory policy and regulations system in herbal medicine industry advanced countries (US, Germany, Japan, China). Using questionnaire survey and expert symposium, the influences of the key herbal medicine related policies on “market mechanism”, “business strategy”, and “competitive advantage” will be revealed as well. Furthermore, the worldwide development tends and policy information will be compared with the present regulation, policies and difficulties in Taiwan, to state opinions and revise the irrelevant regulations system. In addition, all the data brought by this project will be well collected and assembled for the publication of the 2009 Taiwan herbal medicine industry yearbook, the primary coverage includes: present situation and the trend of development on global herbal medicine industry, the introductions of major herbal medicine industries advanced countries, the new technical tendencies, and local herbal medicine company name list. The yearbook will provide sufficient references and information for industry, government officers and researchers.
關鍵字:Taiwan;Chinese medicine;Regulatory policy;Laws and regulations